Author:
Locatelli Marzia,Criscitiello Carmen,Esposito Angela,Minchella Ida,Goldhirsch Aron,Cipolla Carlo,Curigliano Giuseppe
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference89 articles.
1. Shah RR (2006) Can pharmacogenetics help rescue drugs withdrawn from the market? Pharmacogenomics 7(6):889–908
2. Roden DM (2004) Drug-induced prolongation of the QT interval. N Engl J Med 350:1013–1022
3. The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs. Available at: http://www.fda.gov/cder/calendar/meeting/qt4jam.pdf . Accessed March 25, 1997.
4. Food and Drug Administration (2005) International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. Fed Regist 70:61134–61135
5. Strevel EL, Ing DJ, Siu LL (2007) Molecularly targeted oncology therapeutics and prolongation of the QT interval. J Clin Oncol 25:3362–3371
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献